Latest news
Gland Pharma Signs Strategic MSA for 55 Injectable Products, Eyes USD 100M Annual Revenue Potential - Medical DialoguesMedical Dialogues · Mon, 10 Aug 2026 05:30:27 GMTGland Pharma Stock in Focus: Company Signs Strategic CDMO Deal, Revenue Potential of $100 Million - Legal ParivarLegal Parivar · Sun, 09 Aug 2026 12:37:13 GMT